The potential of lemon balm (Melissa officinalis L.) essential oil as an anti-anxiety agent - is the citronellal the activity carrier?

[1]  Tadaaki Satou,et al.  Effects of Inhalation of Essential Oil From Pelargonium graveolens on the Autonomic Nervous System of Awake Mice , 2022, Natural Product Communications.

[2]  M. Howes,et al.  New Insights Into the Anticonvulsant Effects of Essential Oil From Melissa officinalis L. (Lemon Balm) , 2021, Frontiers in Pharmacology.

[3]  Pavle J. Randjelović,et al.  Lemon balm (Melissa officinalis L.) essential oil and citronellal modulate anxiety-related symptoms - In vitro and in vivo studies. , 2021, Journal of ethnopharmacology.

[4]  M. Mirghafourvand,et al.  The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta‐analysis , 2021, Phytotherapy research : PTR.

[5]  G. Di Giovanni,et al.  Effects of Different Anxiety Levels on the Behavioral Patternings Investigated through T-pattern Analysis in Wistar Rats Tested in the Hole-Board Apparatus , 2021, Brain sciences.

[6]  J. Simal-Gándara,et al.  Minerals, Essential Oils, and Biological Properties of Melissa officinalis L. , 2021, Plants.

[7]  S. Sadigh-Eteghad,et al.  Melissa officinalis L. hydro‐alcoholic extract inhibits anxiety and depression through prevention of central oxidative stress and apoptosis , 2020, Experimental physiology.

[8]  I. Ilić,et al.  Toxic essential oils, part VI: Acute oral toxicity of lemon balm (Melissa officinalis L.) essential oil in BALB/c mice. , 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[9]  S. Malami,et al.  Anxiolytic-Like Effect of Methanol Leaf Extract of Laggera aurita Linn. F. (Asteraceae) in Mice , 2018 .

[10]  Pavle J. Randjelović,et al.  Prevalence of self-medication practice with herbal products among non-psychotic psychiatric patients from southeastern Serbia: A cross-sectional study , 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[11]  Murray B Stein,et al.  Anxiety , 2017, The Lancet.

[12]  A. Sahebkar,et al.  Melissa officinalis L. - A review of its traditional uses, phytochemistry and pharmacology. , 2016, Journal of ethnopharmacology.

[13]  B. Bandelow,et al.  Epidemiology of anxiety disorders in the 21st century , 2015, Dialogues in clinical neuroscience.

[14]  A. Atanasov,et al.  Ethnopharmacological in vitro studies on Austria's folk medicine—An unexplored lore in vitro anti-inflammatory activities of 71 Austrian traditional herbal drugs , 2013, Journal of ethnopharmacology.

[15]  G. Thornicroft,et al.  Mental illness stigma, help seeking, and public health programs. , 2013, American journal of public health.

[16]  D. Silveira,et al.  Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: Influence of administration and gender , 2012, Indian journal of pharmacology.

[17]  N. Singewald,et al.  The clinical implications of mouse models of enhanced anxiety. , 2011, Future neurology.

[18]  J. Lépine,et al.  The increasing burden of depression , 2011, Neuropsychiatric disease and treatment.

[19]  D. Béracochéa,et al.  Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[20]  A. Jäger,et al.  Neuroprotective and Neurological Properties of Melissa officinalis , 2009, Neurochemical Research.

[21]  E. Perry,et al.  Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti‐agitation properties: focus on ligand‐gated channels , 2009, The Journal of pharmacy and pharmacology.

[22]  D. Baldwin.  Room for improvement in the pharmacological treatment of anxiety disorders. , 2008, Current pharmaceutical design.

[23]  Gillian R Brown,et al.  The exploratory behaviour of rats in the hole-board apparatus: Is head-dipping a valid measure of neophilia? , 2008, Behavioural Processes.

[24]  D. Baldwin,et al.  Generalised anxiety disorder , 2006, The Lancet.

[25]  C. DeVane,et al.  Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression. , 2005, The American journal of managed care.

[26]  E. Basch,et al.  Catherine Ulbricht, PharmD, MBA(C), Column Editor Lemon Balm (Melissa officinalis L.) , 2005 .

[27]  P. Alves,et al.  Melissa officinalis L. essential oil: antitumoral and antioxidant activities , 2004, The Journal of pharmacy and pharmacology.

[28]  Dan J Stein,et al.  Animal models of anxiety disorders , 2003, Current psychiatry reports.

[29]  M. Hascöet,et al.  A New Approach to the Light/Dark Test Procedure in Mice , 1998, Pharmacology Biochemistry and Behavior.

[30]  Y. Ichimaru,et al.  5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. , 1995, Japanese journal of pharmacology.

[31]  C. Belzung,et al.  Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety , 1994, Physiology & Behavior.

[32]  S. Handley,et al.  Evaluation of marble-burying behavior as a model of anxiety , 1991, Pharmacology Biochemistry and Behavior.

[33]  D. Treit.  Animal models for the study of anti-anxiety agents: A review , 1985, Neuroscience & Biobehavioral Reviews.

[34]  E. O. Alvarez,et al.  Further evidence that histamine in hippocampus affects the exploratory behavior in the rat , 1985, Physiology & Behavior.

[35]  F. Goodwin,et al.  Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines , 1980, Pharmacology Biochemistry and Behavior.

[36]  B. S,et al.  Pharmacogenomic assessment of herbal drugs in affective disorders. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.